Thomas P. Bersot
Thomas P. Bersot publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Cancer, Lipids, and Metabolism.
- World rank
- #573,420 of 7,710,434 ranked researchers
- Rank in United States
- #197,571 of 1,627,098
- Works
- 54
- Citations
- 3.2k
- Citations per work
- 60.0
What does Thomas P. Bersot research?
Thomas P. Bersot's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3462.2%
- Medicine3462.2%
- Everything else1120.9%
- Life Sciences916.9%
- 1Endocrinology, Diabetes and Metabolism25% of their works
- 2Surgery18% of their works
- 3Epidemiology12% of their works
- 4Cancer Research10% of their works
- 5Molecular Biology7% of their works
- 6Cardiology and Cardiovascular Medicine7% of their works
Research topics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipoproteins and Cardiovascular Health
- Cancer, Lipids, and Metabolism
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Lipid metabolism and disorders
- Peroxisome Proliferator-Activated Receptors
- Genetic Associations and Epidemiology
Which keywords describe Thomas P. Bersot's research?
The keywords of their largest research topics: Metabolic Syndrome, Insulin Resistance, Cholesterol, Obesity, Cardiovascular Disease, Atherosclerosis, Diabetes and Statins.
- Genetic Variation
- PPARs
- ANGPTL3
- Adipokines
- NAFLD
- Inflammation
- Adipose Tissue
- Cardiovascular Disease Prevention
- Glucose Metabolism
- Statins
- Atherosclerosis
- Obesity
- Insulin Resistance
- Metabolic Syndrome
- Cholesterol
- Cardiovascular Disease
- Diabetes
- C-Reactive Protein
- Lifestyle Intervention
- Cholesterol-lowering
- Fatty Acid Synthase
- Lipid Metabolism
- NASH
- Macrophages
- Lipoprotein Lipase
- Peroxisome Proliferator-Activated Receptors
- Genome-Wide Association
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 27 words, with their numbers
- Metabolic Syndrome574 topics
- Insulin Resistance503 topics
- Cholesterol452 topics
- Obesity453 topics
- Cardiovascular Disease402 topics
- Atherosclerosis392 topics
- Diabetes372 topics
- Statins372 topics
- C-Reactive Protein322 topics
- Glucose Metabolism321 topic
- Lifestyle Intervention321 topic
- Cardiovascular Disease Prevention241 topic
- Cholesterol-lowering241 topic
- Adipose Tissue152 topics
- Fatty Acid Synthase131 topic
- Inflammation132 topics
- Lipid Metabolism131 topic
- NAFLD101 topic
- NASH101 topic
- Adipokines81 topic
- Macrophages81 topic
- ANGPTL371 topic
- Lipoprotein Lipase71 topic
- PPARs51 topic
- Peroxisome Proliferator-Activated Receptors51 topic
- Genetic Variation31 topic
- Genome-Wide Association31 topic
Where does Thomas P. Bersot work?
Thomas P. Bersot's main affiliation in the publication record is Gladstone Institutes, United States.
How many publications and citations does Thomas P. Bersot have?
OpenAlex counts 54 works and 3,241 citations for Thomas P. Bersot, an h-index of 30, ranking #573,420 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas P. Bersot. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.